Regenxbio Inc (RGNX)

SG&A Expenses

$21.62M

Quarterly · Period ending: · USD

RGNX logo

RGNX SG&A Expenses

Latest reported$21.62M
RGNX Quarterly SG&A Expenses ($634.00K → $21.62M)
High-resolution chart · PNG

RGNX sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
21,616,000
21,306,000
22,380,000
20,253,000
19,883,000
20,347,000
20,051,000
19,422,000
18,855,000
18,291,000
19,079,000
23,083,000
23,698,000
22,634,000
21,210,000
20,921,000
20,832,000
22,318,000
22,040,000
21,030,000
18,425,000
17,838,000
17,571,000
15,859,000
15,554,000
14,833,000
14,450,000
12,402,000
13,405,000
11,558,000
11,144,000
9,008,000
8,318,000
8,380,000
4,808,000
9,444,000
6,355,000
6,622,000
5,742,000
6,200,000
6,169,000
5,479,000
4,232,000
2,567,000
3,397,000
1,716,000
1,119,000
1,070,000
1,026,000
634,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.